Home > Products > CD20 & CD28 > Recombinant Anti-CD20 x Anti-CD28 Bispecific Antibody (Triple Body)

Recombinant Anti-CD20 x Anti-CD28 Bispecific Antibody (Triple Body)  (TRIB-050)

Recombinant Anti-CD20 x Anti-CD28 Bispecific Antibody (Triple Body) is designed to be expressed as two polypeptide chains respectively. The Fd fragment and LC from an anti-CD20 antibody are both extended with the scFv fragment from an anti-CD28 antibody. This BsAb can retarget T cells to tumor cells. It is designed for the research of Lymphoma therapy.

Specifications

Targets
CD20 & CD28
Type
Triple Body
Species Reactivity
Human
Target 1
CD20
Host Animal 1
Mouse
Target 2
CD28
Host Animal 2
Mouse
Application
FuncS; Promising therapeutic agent
Related Disease
Lymphoma

Targets

Target 1
CD20
Gene ID
UniProt ID
Alternative Names
MS4A1; membrane-spanning 4-domains, subfamily A, member 1; B1; S7; Bp35; CD20; CVID5; MS4A2; LEU-16; B-lymphocyte antigen CD20; CD20 antigen; CD20 receptor; leukocyte surface antigen Leu-16; B-lymphocyte cell-surface antigen B1
Target 2
CD28
Gene ID
UniProt ID
Alternative Names
CD28; CD28 molecule; Cluster of Differentiation 28; Tp44; T-cell-specific surface glycoprotein CD28; CD28 antigen

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CD20 x Anti-CD28 Bispecific Antibody (Triple Body) (TRIB-050). Click the button below to contact us or submit your feedback about this product.

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Welcome! For price inquiries, we will get back to you as soon as possible.

To order, please email

INQUIRY
Related products of "CD20 & CD28"
Online Inquiry

24x7 Service quality
USA

Tel:
Fax:
Email:

UK

Tel:
Email:

Germany

Tel:
Email: